Rockefeller Capital Management L.P. - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$33,000
+73.7%
1,2110.0%0.00%
Q1 2021$19,000
+111.1%
1,211
+132.4%
0.00%
Q4 2020$9,000
+28.6%
5210.0%0.00%
Q3 2020$7,000
-22.2%
5210.0%0.00%
Q2 2020$9,000
+80.0%
5210.0%0.00%
Q1 2020$5,000
+25.0%
5210.0%0.00%
Q4 2019$4,000
-20.0%
5210.0%0.00%
Q3 2019$5,0005210.00%
Other shareholders
TRANSLATE BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,922,008$31,925,00048.23%
Omega Fund Management, LLC 2,437,603$19,842,0006.32%
FRAZIER MANAGEMENT LLC 2,182,789$17,768,0002.98%
Baupost Group 17,544,239$141,358,0001.56%
RTW INVESTMENTS, LP 3,304,808$26,901,0001.02%
Camber Capital Management LP 1,500,000$12,210,0000.62%
DAFNA Capital Management LLC 179,845$1,464,0000.50%
Bain Capital Public Equity Management II, LLC 416,670$3,392,0000.32%
Rock Springs Capital Management LP 950,000$7,733,0000.24%
Artal Group S.A. 650,000$5,291,0000.20%
View complete list of TRANSLATE BIO INC shareholders